Dyne Therapeutics, Inc. (DYN)
18.75
-0.09
(-0.48%)
USD |
NASDAQ |
Apr 06, 09:50
Dyne Therapeutics Enterprise Value : 2.168B for April 2, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.017B |
| Arrowhead Pharmaceuticals, Inc. | 8.312B |
| Amicus Therapeutics, Inc. | 4.683B |
| Insmed, Inc. | 34.34B |
| EyePoint Plc | 834.70M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -111.96M |
| Total Expenses (Quarterly) | 111.96M |
| EPS Diluted (Quarterly) | -0.7584 |
| Earnings Yield | -18.90% |
| Normalized Earnings Yield | -18.90 |